ACSL4 and COVID-19: One postulated mechanism for the pioglitazone effect on COVID-19 is via inhibition of acyl-coenzyme A synthetase long-chain family member 4 (ACSL4), which is known to regulate an iron-dependent programmed cell death process called ferroptosis.